BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11772424)

  • 1. Peroxisome proliferator-activated receptors.
    Ziouzenkova O; Perrey S; Marx N; Bacqueville D; Plutzky J
    Curr Atheroscler Rep; 2002 Jan; 4(1):59-64. PubMed ID: 11772424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.
    Plutzky J
    Curr Atheroscler Rep; 2000 Jul; 2(4):327-35. PubMed ID: 11122762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis.
    Neve BP; Fruchart JC; Staels B
    Biochem Pharmacol; 2000 Oct; 60(8):1245-50. PubMed ID: 11007963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging.
    Pineda Torra I; Gervois P; Staels B
    Curr Opin Lipidol; 1999 Apr; 10(2):151-9. PubMed ID: 10327283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis.
    Plutzky J
    Am J Cardiol; 2003 Aug; 92(4A):34J-41J. PubMed ID: 12957325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy].
    Bełtowski J; Wójcicka G; Jamroz A
    Postepy Hig Med Dosw; 2003; 57(2):199-217. PubMed ID: 12866356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptors: are they involved in atherosclerosis progression?
    Puddu P; Puddu GM; Muscari A
    Int J Cardiol; 2003 Aug; 90(2-3):133-40. PubMed ID: 12957742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptors in endothelial cell biology.
    Plutzky J
    Curr Opin Lipidol; 2001 Oct; 12(5):511-8. PubMed ID: 11561170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function.
    Chinetti G; Fruchart JC; Staels B
    Curr Opin Lipidol; 2003 Oct; 14(5):459-68. PubMed ID: 14501584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and additional vascular effects of thiazolidinediones.
    Martens FM; Visseren FL; Lemay J; de Koning EJ; Rabelink TJ
    Drugs; 2002; 62(10):1463-80. PubMed ID: 12093315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis.
    Fruchart JC; Duriez P; Staels B
    Curr Opin Lipidol; 1999 Jun; 10(3):245-57. PubMed ID: 10431661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
    Chinetti G; Fruchart JC; Staels B
    Z Kardiol; 2001; 90 Suppl 3():125-32. PubMed ID: 11374025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N; Duez H; Fruchart JC; Staels B
    Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor (PPAR)-alpha: a pharmacological target with a promising future.
    van Raalte DH; Li M; Pritchard PH; Wasan KM
    Pharm Res; 2004 Sep; 21(9):1531-8. PubMed ID: 15497675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orphan nuclear receptors find a home in the arterial wall.
    Laffitte BA; Tontonoz P
    Curr Atheroscler Rep; 2002 May; 4(3):213-21. PubMed ID: 11931719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptors in atherosclerosis and inflammation--an update.
    Elangbam CS; Tyler RD; Lightfoot RM
    Toxicol Pathol; 2001; 29(2):224-31. PubMed ID: 11421489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of dysfunctional fatty acid metabolism using peroxisome proliferator activated receptor gamma agonists.
    Oakes ND; Ljung B; Camejo G
    J R Soc Med; 2002; 95 Suppl 42(Suppl 42):33-8. PubMed ID: 12216325
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of PPARs in atherosclerosis.
    Duval C; Chinetti G; Trottein F; Fruchart JC; Staels B
    Trends Mol Med; 2002 Sep; 8(9):422-30. PubMed ID: 12223313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipolytic PPAR activation: new insights into the intersection of triglycerides and inflammation?
    Ziouzenkova O; Plutzky J
    Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):369-75. PubMed ID: 15192437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peroxisome proliferator activated nuclear receptors: possible role in the development of atherosclerosis].
    Evdokimova MA; Zateĭshchikov DA; Sidorenko BA
    Kardiologiia; 2003; 43(11):41-8. PubMed ID: 14671562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.